Dendritic Cell Vaccine for the treatment of Chronic Myeloid Leukemia

Rania Abdalla Hussein Abou El Nour


Abstract


Chronic myeloid leukemia (CML) is defined by a unique molecular event, the BCR-ABL oncogene. The BCR-ABL oncogene presents a good opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also


Other data

Other Titles مصل من الخلايا الفرعية لعلاج اللوكيميا الميلودية المزمنة
Keywords Dendritic Cell Vaccine for the treatment of Chronic Myeloid Leukemia
Issue Date 2009
Description Chronic myeloid leukemia (CML) is defined by a unique molecular event, the BCR-ABL oncogene. The BCR-ABL oncogene presents a good opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also
URI http://research.asu.edu.eg/handle/12345678/2993


File SizeFormat 
94598r2431.pdf218.3 kBAdobe PDFView/Open
Recommend this item

CORE Recommender

Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.